Abstract
Nanotechnology has contributed significantly in the development of nanoparticles for therapy and imaging of a variety of cancer types. The low systemic toxicity of most theranostic nanoparticles can lead to effective cancer treatment, monitoring and imaging, with improved outcomes compared to conventional cancer treatment and imaging options. The current review highlights the major factors associated with the development of polymeric nanoparticles in cancer theranostics, a field which has gained significant interest in recent years. Fundamental aspects for the synthesis, modification, and characterization of polymeric nanoparticles are discussed with key advancements in passive and active targeting using such nanoparticles provided. Also indirect factors such as physical and biological barriers in biological systems where particles are used for cancer theranostics are presented. The goal of this review is to provide researchers sufficient scientific information for constructing effective nanocarriers for cancer therapy and imaging.
Similar content being viewed by others
Data Availability
Not applicable
Abbreviations
- PEG:
-
polyethylene glycol
- PDLLA:
-
poly(d,l-lactic acid)
- PLGA:
-
poly(lactic-co-glycolic acid)
- PCL:
-
poly(ε-caprolactone)
- PVA:
-
polyvinyl alcohol
- MPS:
-
mononuclear phagocytic system
- IFP:
-
interstitial fluid pressure
- ECM:
-
extracellular matrix
- EPR:
-
enhanced permeability and retention
- O/W:
-
oil-in-water
- W/O/W:
-
water-in-oil-in-water
- PDMS:
-
polydimethylsiloxane
- PRINT:
-
Particle Replication In Non-wetting Templates
- MNPs:
-
magnetite nanoparticles
- MRI:
-
magnetic resonance imaging
- PHBV:
-
poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
- PDA:
-
polydopamine
- PTX:
-
paclitaxel
- RGD:
-
arginine-glycine-aspartic acid
- DIR or DiR:
-
1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide
- FITC:
-
fluorescein isothiocyanate
- PCLA-PEG-PCLA:
-
poly(ε-caprolactone-co-lactide)-b-poly(ethylene glycol)-b-poly(ε-caprolactone-co-lactide)
- DOX:
-
doxorubicin
- Dox:
-
doxorubicin
- Ce6:
-
chlorin e6
- PDT:
-
photodynamic therapy
- PA:
-
photoacoustic
- SRB:
-
sulforhodamine B
- CUR:
-
curcumin
- RNA:
-
ribonucleic acid
- Apts:
-
aptamers
- EpCAM:
-
epithelial cell adhesion molecule
- PEI:
-
polyethylenimine
- bDNA:
-
bulk DNA
- SIM:
-
simvastatin
- IONPs:
-
iron oxide nanoparticles
- VCR:
-
vincristine
- VRP:
-
verapamil
- PDDA:
-
poly(dimethyldiallylammonium chloride)
- Cy5.5:
-
cyanine5.5
- PXN:
-
paxillin
- gRNA:
-
guide RNA
- HA:
-
hyaluronic acid
- Gd-DTPA:
-
diethylenetriaminepentaacetic acid-gadolinium
- Doc:
-
docetaxel
- siRNA:
-
small interfering RNA
- Tg:
-
6-thioguanine
- BODIPY:
-
ethynyl-boron-dipyrromethene
- SPIONs:
-
superparamagnetic iron oxide nanoparticles
- EDC:
-
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
- DCC:
-
dicyclohexylcarbodiimide
- NHS:
-
N-hydroxysuccinimide
- Sulfo-NHS:
-
N-hydroxysulfosuccinimide
- SATA:
-
N-succinimidyl-S-acetylthioacetate
- ROS:
-
reactive oxygen species
- Pc:
-
phthalocyanine
- pNIPAM:
-
poly(N-isopropylacrylamide)
- PMMA:
-
poly(methyl methacrylate)
- MPN:
-
metal-phenolic network
- CS:
-
chitosan
- AA:
-
acrylic acid
- PPV:
-
poly(p-phenylenevinylene)
- EGFR:
-
epidermal growth factor receptor
- FA:
-
folic acid
- Pdots:
-
polymer dots
- PPy:
-
polypyrrole
- AAC:
-
azide-alkyne cycloaddition
- MPU:
-
multiblock polyurethane
- DMSO:
-
dimethyl sulfoxide
- NIR:
-
near-infrared
- PTT:
-
photothermal therapy
- ACQ:
-
aggregation caused quenching
- MFI:
-
median fluorescence intensity
- DEM:
-
dimethyl ester
- OR-PAM:
-
optical-resolution photoacoustic microscopy
- SDS:
-
sodium dodecyl sulfate
- NIPAm:
-
N-isopropylacrylamide
- BIS:
-
N,N′-methylenebisacrylamide
- APS:
-
ammonium persulfate
- TEMED:
-
tetramethylethylenediamine
- LCST:
-
lower critical solution temperature
- PCPDTBT:
-
poly[2,6-(4,4-bis-(2-ethylhexyl)−4H-cyclopenta[2,1-b;3,4-b']dithiophene)-alt-4,7(2,1,3-benzothiadiazole)]
- CP-NPs:
-
conjugated polymeric nanoparticles
- DPBF:
-
1,3-Diphenylisobenzofuran
- HPMA:
-
N-(2-hydroxypropylmethyl) acrylamide
- CMC:
-
critical micelle concentration
- DTT:
-
dithiothreitol
- PDI:
-
polydispersity index
- TGI:
-
tumor growth inhibition
- MVD:
-
microvessel density
- DPNs:
-
discoidal polymeric nanoparticles
- USPIOs:
-
ultra-small super-paramagnetic iron oxide nanoparticles
- RhB:
-
rhodamine B
- nAChR:
-
nicotinic acetylcholine receptor
- RVG:
-
rabies virus glycoprotein
- THF:
-
tetrahydrofuran
- PFBTDBT10:
-
poly[(9,9-dihexylfluorene)-co-2,1,3-benzothiadiazole]
- ECM:
-
extracellular matrix
- CMCh:
-
carboxymethyl chitosan
- BAPE:
-
4-hydroxymethyl-pinacol phenylborate
- CMCh-BAPE:
-
carboxymethyl chitosan and benzeneboronic acid pinacol ester
- ICG:
-
indocyanine green
- ApoE:
-
apolipoprotein-E
- LDL:
-
low-density lipoprotein
- US:
-
ultrasound
- RF:
-
radio frequency
- Gd:
-
gadolinium
- SPIO:
-
superparamagnetic iron oxide
- CT:
-
computed tomography
- PET:
-
positron emission tomography
- SPECT:
-
single-photon emission computerized tomography
- LPHNs:
-
polymer-lipid hybrid nanoparticles
- PSMs:
-
polymer-surfactant micelles
- PSNPs:
-
polymer-surfactant nanoparticles
- CDs:
-
cyclodextrins
- PDCs:
-
Polymer-drug conjugates
- Polysorbate 20:
-
polyoxyethylene sorbitan monolaurate
- NEM:
-
nano-embedded particles
- NLS:
-
nuclear localization sequence
- PVOH:
-
polyvinyl alcohol
- CuAAC:
-
copper-catalyzed azide-alkyne cycloaddition
- pNIPAAm:
-
poly(N-isopropylacrylamide)
- HSA:
-
human serum albumin
- MEH-PPV:
-
poly[2-methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylenevinylene]
- GSH:
-
glutathione
- DAPI:
-
4′,6-diamidino-2-phenylindole
- TFP:
-
thermoresponsive fluorescent particles
- BPLP:
-
biodegradable photo-luminescent polymer
- BPLP-Ser:
-
biodegradable photo-luminescent polymer with serine
- SBC:
-
sodium bicarbonate
- BPLP-SBC:
-
biodegradable photo-luminescent polymer with sodium bicarbonate
- TFP-SBC:
-
thermoresponsive fluorescent particles with sodium bicarbonate
- DI:
-
deionized
- WBPLP-AH:
-
water-soluble BPLP-allylamine crosslinked polymer
- MES:
-
2-(N-morpholino)ethanesulfonic acid
- GFLG:
-
glycylphenylalanylleucylglycyl
- RAFT:
-
reversible addition-fragmentation chain-transfer
- CTA-GFLGKGLFG-CTA:
-
N-glycylphenylalanylleucylglycyl di-4-cyano-4-(phenylcarbonothioylthio)pentanoate
- VA044:
-
2,2,-[azobis(1-methylethylidene)]bis[4,5-dihydro-1H-imidazole] dihydrochloride
- MA-GFLG-PTX:
-
N-methacryloyl-glycylphenylalanylleucylglycyl-paclitaxel
- PTEMA:
-
N-[2-(2-pyridyldithio)]ethyl methacrylamide
- MR:
-
magnetic resonance
- FI:
-
fluorescence imaging
- DD:
-
drug delivery
- USI:
-
ultrasound imaging
- PAI:
-
photoacoustic imaging
- RT:
-
radiotherapy
- DTX:
-
docetaxel
- PBS:
-
phosphate buffered saline
- MC:
-
methylene chloride
- W/O:
-
water-in-oil
- GNPs:
-
gas-generating nanoparticles
- PLG:
-
poly(d,l-lactide-co-glycolide)
- DiI:
-
1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate
- PCPDTBSe:
-
poly[4,4-bis(2-ethylhexyl)-cyclopenta[2,1-b;3,4-b′]dithiophene-2,6-diyl-alt-2,1,3-benzoselenadiazole-4,7-diyl]
- HDAPPs:
-
hybrid donor acceptor polymer particles
- CRC:
-
colorectal cancer
- BBB:
-
blood-brain barrier
- PS 80:
-
polysorbate 80
- ICGD:
-
indocyanine green derivative
- SN38 or SN-38:
-
7-ethyl-10-hydroxycamptothecin
- Pba:
-
pheophorbide a
- CPT:
-
camptothecin
- VEGFR:
-
vascular endothelial growth factor receptor
- MTD::
-
maximum tolerated dose
- NSCLC:
-
non-small cell lung cancer
- PGlu:
-
polyglutamate
- DLT:
-
dose-limiting toxicity
References
Chakraborty, S., & Rahman, T. (2012). The difficulties in cancer treatment. Ecancermedicalscience., 6.
Chen, X., Gole, J., Gore, A., He, Q., Lu, M., Min, J., et al. (2020). Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nature Communications., 11(1), 1–10.
Liston, D. R., & Davis, M. (2017). Clinically relevant concentrations of anticancer drugs: A guide for nonclinical studies guide to clinical exposures of anticancer drugs. Clinical Cancer Research., 23(14), 3489–3498.
Meng, Q., & Li, Z. (2013). Molecular imaging probes for diagnosis and therapy evaluation of breast cancer. International Journal of Biomedical Imaging, 2013.
Li, C., Liu, C., Fan, Y., Ma, X., Zhan, Y., Lu, X., et al. (2021). Recent development of near-infrared photoacoustic probes based on small-molecule organic dye. RSC Chemical Biology, 2(3), 743–758.
Narvekar, M., Xue, H. Y., Eoh, J. Y., & Wong, H. L. (2014). Nanocarrier for poorly water-soluble anticancer drugs—barriers of translation and solutions. Aaps Pharmscitech, 15(4), 822–833.
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010). Imaging and drug delivery using theranostic nanoparticles. Advanced Drug Delivery Reviews, 62(11), 1052–1063.
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. P., Acosta-Torres, L. S., et al. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of Nanobiotechnology, 16(1), 1–33.
Siafaka, P. I., Okur, N. Ü., Karantas, I. D., Okur, M. E., & Gündoğdu, E. A. (2021). Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian Journal of Pharmaceutical Sciences, 16(1), 24–46.
Maeda, H. (2013). The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Science, 104(7), 779–789.
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., et al. (2016). Analysis of nanoparticle delivery to tumours. Nature Reviews Materials, 1(5), 1–12.
Finbloom, J. A., Sousa, F., Stevens, M. M., & Desai, T. A. (2020). Engineering the drug carrier biointerface to overcome biological barriers to drug delivery. Advanced Drug Delivery Reviews, 167, 89–108.
Cooley, M., Sarode, A., Hoore, M., Fedosov, D. A., Mitragotri, S., & Gupta, A. S. (2018). Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale. Nanoscale, 10(32), 15350–15364.
Yu, E., Sancenón, F., Aznar, E., Martínez-Máñez, R., Marcos, M. D., Hajipour, M. J., et al. (2017). Future perspective on the smart delivery of biomolecules. Drug Delivery Systems, 1, 363.
Jain, R. K., & Stylianopoulos, T. (2010). Delivering nanomedicine to solid tumors. Nature Reviews Clinical Oncology, 7(11), 653–664.
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., et al. (2000). Openings between defective endothelial cells explain tumor vessel leakiness. The American Journal of Pathology, 156(4), 1363–1380.
Kulkarni, S. A., & Feng, S.-S. (2013). Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharmaceutical Research, 30(10), 2512–2522.
Faraji, A. H., & Wipf, P. (2009). Nanoparticles in cellular drug delivery. Bioorganic & Medicinal Chemistry, 17(8), 2950–2962.
Zhong, Q., Merkel, O. M., Reineke, J. J., & da Rocha, S. R. (2016). Effect of the route of administration and PEGylation of poly (amidoamine) dendrimers on their systemic and lung cellular biodistribution. Molecular Pharmaceutics, 13(6), 1866–1878.
Battaglia, L., Panciani, P. P., Muntoni, E., Capucchio, M. T., Biasibetti, E., De Bonis, P., et al. (2018). Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opinion on Drug Delivery, 15(4), 369–378.
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015). Cancer active targeting by nanoparticles: a comprehensive review of literature. Journal of Cancer Research and Clinical Oncology, 141(5), 769–784.
Nag, O. K., & Delehanty, J. B. (2019). Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics, 11(10), 543.
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016). The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine, 11(6), 673–692.
Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V. (2018). Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types. Frontiers in Pharmacology, 9, 27.
Boedtkjer, E., & Pedersen, S. F. (2020). The acidic tumor microenvironment as a driver of cancer. Annual Review of Physiology, 82, 103–126.
Wu, W., Luo, L., Wang, Y., Wu, Q., Dai, H.-B., Li, J.-S., et al. (2018). Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications. Theranostics, 8(11), 3038.
Li, M., Zhao, G., Su, W.-K., & Shuai, Q. (2020). Enzyme-responsive nanoparticles for anti-tumor drug delivery. Frontiers in Chemistry, 8, 647.
Ferretti, S., Allegrini, P. R., Becquet, M. M., & McSheehy, P. M. (2009). Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics. Neoplasia, 11(9), 874–881.
Blanco, E., Shen, H., & Ferrari, M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology, 33(9), 941–951.
Li, M., Zhang, Y., Zhang, Q., & Li, J. (2022). Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines. Materials Today Bio, 100364.
Siemann, D. W. (2011). The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by tumor-vascular disrupting agents. Cancer Treatment Reviews, 37(1), 63–74.
Kalyane, D., Raval, N., Maheshwari, R., Tambe, V., Kalia, K., & Tekade, R. K. (2019). Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Materials Science and Engineering: C, 98, 1252–1276.
Wu, S., Zhu, W., Thompson, P., & Hannun, Y. A. (2018). Evaluating intrinsic and non-intrinsic cancer risk factors. Nature Communications, 9(1), 1–12.
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., et al. (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research, 25(9), 2097–2116.
Ensign, L. M., Cone, R., & Hanes, J. (2012). Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Advanced Drug Delivery Reviews, 64(6), 557–570.
Witten, J., & Ribbeck, K. (2017). The particle in the spider's web: Transport through biological hydrogels. Nanoscale, 9(24), 8080–8095.
Neagu, M., Piperigkou, Z., Karamanou, K., Engin, A. B., Docea, A. O., Constantin, C., et al. (2017). Protein bio-corona: critical issue in immune nanotoxicology. Archives of Toxicology, 91(3), 1031–1048.
Trimble, W. S., & Grinstein, S. (2015). Barriers to the free diffusion of proteins and lipids in the plasma membrane. Journal of Cell Biology, 208(3), 259–271.
Mulhall, H. J., Hughes, M. P., Kazmi, B., Lewis, M. P., & Labeed, F. H. (2013). Epithelial cancer cells exhibit different electrical properties when cultured in 2D and 3D environments. Biochimica et Biophysica Acta (BBA)-General Subjects, 1830(11), 5136–5141.
Chen, B., Le, W., Wang, Y., Li, Z., Wang, D., Ren, L., et al. (2016). Targeting negative surface charges of cancer cells by multifunctional nanoprobes. Theranostics, 6(11), 1887.
Augustine, R., Hasan, A., Primavera, R., Wilson, R. J., Thakor, A. S., & Kevadiya, B. D. (2020). Cellular uptake and retention of nanoparticles: Insights on particle properties and interaction with cellular components. Materials Today Communications, 25, 101692.
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010). Endocytosis of nanomedicines. Journal of Controlled Release, 145(3), 182–195.
Pelkmans, L., & Helenius, A. (2002). Endocytosis via caveolae. Traffic, 3(5), 311–320.
Kirkham, M., Parton, R. G., et al. (2005). Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1745(3), 273–286.
Rennick, J. J., Johnston, A. P., & Parton, R. G. (2021). Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nature Nanotechnology, 16(3), 266–276.
Means, N., Elechalawar, C. K., Chen, W. R., Bhattacharya, R., & Mukherjee, P. (2021). Revealing macropinocytosis using nanoparticles. Molecular Aspects of Medicine, 100993.
Liu, C.-G., Han, Y.-H., Kankala, R. K., Wang, S.-B., & Chen, A.-Z. (2020). Subcellular performance of nanoparticles in cancer therapy. International Journal of Nanomedicine, 15, 675.
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020). Cancer-targeting nanoparticles for combinatorial nucleic acid delivery. Advanced Materials, 32(13), 1901081.
Jin, Y., Zakeri, S. E., Bahal, R., & Wiemer, A. J. (2022). New technologies bloom together for bettering cancer drug conjugates. Pharmacological Reviews, 74(3), 680–711.
Ughachukwu P, Unekwe P. Efflux Pump. Mediated Resistance in Chemotherapy. Annals of Medical and Health Sciences Research, 2(2):191-198.
Perumal, V., Sivakumar, P. M., Zarrabi, A., Muthupandian, S., Vijayaraghavalu, S., Sahoo, K., et al. (2019). Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis. Journal of Photochemistry and Photobiology B: Biology, 199, 111630.
Bu, L., Ma, X., Tu, Y., Shen, B., & Cheng, Z. (2013). Optical image-guided cancer therapy. Current Pharmaceutical Biotechnology, 14(8), 723–732.
Mi, P. (2020). Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics, 10(10), 4557.
Reisch, A., & Klymchenko, A. S. (2016). Fluorescent polymer nanoparticles based on dyes: seeking brighter tools for bioimaging. Small, 12(15), 1968–1992.
Yang, Y., Tu, D., Zhang, Y., Zhang, P., & Chen, X. (2021). Recent advances in design of lanthanide-containing NIR-II luminescent nanoprobes. Iscience, 24(2), 102062.
Wu, Z., Midgley, A. C., Kong, D., & Ding, D. (2022). Organic persistent luminescence imaging for biomedical applications. Materials Today Bio, 100481.
Yusefi, H., & Helfield, B. (2022). Ultrasound contrast imaging: Fundamentals and emerging technology. Frontiers in Physics, 100.
Duan, L., Yang, L., Jin, J., Yang, F., Liu, D., Hu, K., et al. (2020). Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications. Theranostics, 10(2), 462.
Fu, L., & Ke, H.-T. (2016). Nanomaterials incorporated ultrasound contrast agents for cancer theranostics. Cancer Biology & Medicine, 13(3), 313.
Weber, J., Beard, P. C., & Bohndiek, S. E. (2016). Contrast agents for molecular photoacoustic imaging. Nature Methods, 13(8), 639–650.
Upputuri, P. K., & Pramanik, M. (2020). Recent advances in photoacoustic contrast agents for in vivo imaging. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 12(4), e1618.
Weishaupt, D., Köchli, V. D., Marincek, B., Froehlich, J. M., Nanz, D., & Pruessmann, K. P. (2006). How does MRI work?: an introduction to the physics and function of magnetic resonance imaging. Springer.
Grover, V. P., Tognarelli, J. M., Crossey, M. M., Cox, I. J., Taylor-Robinson, S. D., & McPhail, M. J. (2015). Magnetic resonance imaging: principles and techniques: lessons for clinicians. Journal of Clinical and Experimental Hepatology, 5(3), 246–255.
Gauger, A. J., Hershberger, K. K., & Bronstein, L. M. (2020). Theranostics based on magnetic nanoparticles and polymers: intelligent design for efficient diagnostics and therapy. Frontiers in Chemistry, 8, 561.
Brito, B., Price, T. W., Gallo, J., Bañobre-López, M., & Stasiuk, G. J. (2021). Smart magnetic resonance imaging-based theranostics for cancer. Theranostics, 11(18), 8706.
Nyström, A. M. (2012). Update on Polymer Based Nanomedicine. Smithers Rapra.
Cormode, D. P., Naha, P. C., & Fayad, Z. A. (2014). Nanoparticle contrast agents for computed tomography: a focus on micelles. Contrast Media & Molecular Imaging, 9(1), 37–52.
Lusic, H., & Grinstaff, M. W. (2013). X-ray-computed tomography contrast agents. Chemical Reviews, 113(3), 1641–1666.
Livieratos, L. (2012). Basic principles of SPECT and PET imaging. radionuclide and hybrid bone. Imaging, 345–359.
Unterrainer, M., Eze, C., Ilhan, H., Marschner, S., Roengvoraphoj, O., Schmidt-Hegemann, N.-S., et al. (2020). Recent advances of PET imaging in clinical radiation oncology. Radiation Oncology, 15(1), 1–15.
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022). Radiopharmaceuticals for PET and SPECT imaging: A literature review over the last decade. International Journal of Molecular Sciences, 23(9), 5023.
Wu, S., Helal-Neto, E., Matos, A. P. S., Jafari, A., Kozempel, J., Silva, Y. J. A., et al. (2020). Radioactive polymeric nanoparticles for biomedical application. Drug Delivery, 27(1), 1544–1561.
Parveen, S., & Sahoo, S. K. (2008). Polymeric nanoparticles for cancer therapy. Journal of Drug Targeting, 16(2), 108–123.
Letchford, K., & Burt, H. (2007). A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. European Journal of Pharmaceutics and Biopharmaceutics, 65(3), 259–269.
Elsabahy, M., Heo, G. S., Lim, S.-M., Sun, G., & Wooley, K. L. (2015). Polymeric nanostructures for imaging and therapy. Chemical Reviews, 115(19), 10967–11011.
Zhang, X., Liang, T., & Ma, Q. (2021). Layer-by-Layer assembled nano-drug delivery systems for cancer treatment. Drug Delivery, 28(1), 655–669.
Lima, A. L., Gratieri, T., Cunha-Filho, M., & Gelfuso, G. M. (2022). Polymeric nanocapsules: A review on design and production methods for pharmaceutical purpose. Methods, 199, 54–66.
Das, R., Kumar, H., Choithramani, A., Bothra, G., & Shard, A. (2022). Polymeric nanoparticles to entrap natural drugs for cancer therapy. Polymeric Nanoparticles for the Treatment of Solid Tumors, 167–211.
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., et al. (2017). Cellular uptake of nanoparticles: journey inside the cell. Chemical Society Reviews, 46(14), 4218–4244.
Mendoza-Muñoz, N., Alcalá-Alcala, S., & Quintanar-Guerrero, D. (2016). preparation of polymer nanoparticles by the emulsification-solvent evaporation method: From Vanderhoff’s pioneer approach to recent adaptations. Polymer Nanoparticles for Nanomedicines: A guide for their design. Preparation and Development, 87–121.
Yan, X., Bernard, J., & Ganachaud, F. (2021). Nanoprecipitation as a simple and straightforward process to create complex polymeric colloidal morphologies. Advances in Colloid and Interface Science, 294, 102474.
Tao, J., Chow, S. F., & Zheng, Y. (2019). Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles. Acta Pharmaceutica Sinica B, 9(1), 4–18.
Rao, J. P., & Geckeler, K. E. (2011). Polymer nanoparticles: Preparation techniques and size-control parameters. Progress in Polymer Science, 36(7), 887–913.
Wang, Y., Byrne, J. D., Napier, M. E., & DeSimone, J. M. (2012). Engineering nanomedicines using stimuli-responsive biomaterials. >Advanced Drug Delivery Reviews, 64(11), 1021–1030.
Upponi, J. R., Jerajani, K., Nagesha, D. K., Kulkarni, P., Sridhar, S., Ferris, C., et al. (2018). Polymeric micelles: theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials, 170, 26–36.
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., et al. (2021). Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions. Journal of Controlled Release, 332, 312–336.
Letchford, K., Zastre, J., Liggins, R., & Burt, H. (2004). Synthesis and micellar characterization of short block length methoxy poly (ethylene glycol)-block-poly (caprolactone) diblock copolymers. Colloids and Surfaces B: Biointerfaces, 35(2), 81–91.
Hibino, M., Tanaka, K., Ouchi, M., & Terashima, T. (2021). Amphiphilic random-block copolymer micelles in water: Precise and dynamic self-assembly controlled by random copolymer association. Macromolecules, 55(1), 178–189.
Schoubben, A., Ricci, M., & Giovagnoli, S. (2019). Meeting the unmet: From traditional to cutting-edge techniques for poly lactide and poly lactide-co-glycolide microparticle manufacturing. Journal of Pharmaceutical Investigation, 49, 381–404.
Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release, 73(2-3), 137–172.
Fournier, E., Dufresne, M.-H., Smith, D. C., Ranger, M., & Leroux, J.-C. (2004). A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharmaceutical Research, 21, 962–968.
Tyrrell, Z. L., Shen, Y., & Radosz, M. (2010). Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Progress in Polymer Science, 35(9), 1128–1143.
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. Journal of Controlled Release, 109(1-3), 169–188.
Tomalia, D. A., Christensen, J. B., & Boas, U. (2012). Dendrimers, dendrons, and dendritic polymers: discovery, applications, and the future. Cambridge University Press.
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., et al. (2014). Dendrimers: synthesis, applications, and properties. Nanoscale Research Letters, 9(1), 1–10.
Saluja, V., Mishra, Y., Mishra, V., Giri, N., & Nayak, P. (2021). Dendrimers based cancer nanotheranostics: An overview. International Journal of Pharmaceutics, 600, 120485.
Noriega-Luna B, Godínez LA, Rodríguez FJ, Rodríguez A, Larrea GZ-Ld, Sosa-Ferreyra C, et al. (2014). Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. Journal of Nanomaterials 2014, 39-.
Medina, S. H., & El-Sayed, M. E. (2009). Dendrimers as carriers for delivery of chemotherapeutic agents. Chemical Reviews, 109(7), 3141–3157.
Maiti, P. K., Çaǧın, T., Wang, G., & Goddard, W. A. (2004). Structure of PAMAM dendrimers: Generations 1 through 11. Macromolecules, 37(16), 6236–6254.
Mohammadi, M., Ramezani, M., Abnous, K., & Alibolandi, M. (2017). Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine. International Journal of Pharmaceutics, 519(1-2), 287–303.
Liu, G.-Y., Chen, C.-J., & Ji, J. (2012). Biocompatible and biodegradable polymersomes as delivery vehicles in biomedical applications. Soft Matter, 8(34), 8811–8821.
Simone, E. A., Dziubla, T. D., & Muzykantov, V. R. (2008). Polymeric carriers: role of geometry in drug delivery. Expert Opinion on Drug Delivery, 5(12), 1283–1300.
Rideau, E., Dimova, R., Schwille, P., Wurm, F. R., & Landfester, K. (2018). Liposomes and polymersomes: a comparative review towards cell mimicking. Chemical Society Reviews, 47(23), 8572–8610.
Robertson, J. D., Rizzello, L., Avila-Olias, M., Gaitzsch, J., Contini, C., Magoń, M. S., et al. (2016). Purification of nanoparticles by size and shape. Scientific Reports, 6(1), 1–9.
O’Neil, C. P., Suzuki, T., Demurtas, D., Finka, A., & Hubbell, J. A. (2009). A novel method for the encapsulation of biomolecules into polymersomes via direct hydration. Langmuir, 25(16), 9025–9029.
Lo, C. H., & Zeng, J. (2023). Application of polymersomes in membrane protein study and drug discovery: Progress, strategies, and perspectives. Bioengineering & Translational Medicine, 8(1), e10350.
Lefley, J., Waldron, C., & Becer, C. R. (2020). Macromolecular design and preparation of polymersomes. Polymer Chemistry, 11(45), 7124–7136.
Durymanov, M., & Reineke, J. (2018). Non-viral delivery of nucleic acids: Insight into mechanisms of overcoming intracellular barriers. Frontiers in Pharmacology, 9, 971.
Vetter, V. C., & Wagner, E. (2022). Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes. Journal of Controlled Release, 346, 110–135.
Shim, M. S., & Kwon, Y. J. (2012). Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Advanced Drug Delivery Reviews, 64(11), 1046–1059.
Zhang, R., Qin, X., Kong, F., Chen, P., & Pan, G. (2019). Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Delivery, 26(1), 328–342.
Shah, S., Famta, P., Raghuvanshi, R. S., Singh, S. B., & Srivastava, S. (2022). Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications. Colloid and Interface Science Communications, 46, 100570.
Teixeira, M., Carbone, C., & Souto, E. (2017). Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Progress in Lipid Research, 68, 1–11.
Raffa, P., Wever, D. A. Z., Picchioni, F., & Broekhuis, A. A. (2015). Polymeric surfactants: synthesis, properties, and links to applications. Chemical Reviews., 115(16), 8504–8563.
Nasef, A. M., Gardouh, A. R., & Ghorab, M. M. (2015). Polymeric nanoparticles: influence of polymer, surfactant and composition of manufacturing vehicle on particle size. World Journal of Pharmaceutical Sciences, 2308–2322.
Karthic, A., Roy, A., Lakkakula, J., Alghamdi, S., Shakoori, A., Babalghith, A. O., et al. (2022). Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review. Frontiers in Cell and Developmental Biology., 10.
Gadade, D. D., Rathi, P. B., Sangshetti, J. N., & Kulkarni, D. A. (2022). Multifunctional cyclodextrin nanoparticles: A promising theranostic tool for strategic targeting of cancer. Polysaccharide Nanoparticles. Elsevier, 485–515.
Wang, Y., Xia, H., Chen, B., & Wang, Y. (2023). Rethinking nanoparticulate polymer–drug conjugates for cancer theranostics. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 15(1), e1828.
Duncan, R., Vicent, M., Greco, F., & Nicholson, R. (2005). Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer. Endocrine Related Cancer, 12(1), S189.
Grillo, R., Gallo, J., Stroppa, D. G., Carbó-Argibay, E., Lima, R., Fraceto, L. F., et al. (2016). Sub-micrometer magnetic nanocomposites: insights into the effect of magnetic nanoparticles interactions on the optimization of SAR and MRI performance. ACS Applied Materials & Interfaces, 8(39), 25777–25787.
Wu, M., Zhong, C., Zhang, Q., Wang, L., Wang, L., Liu, Y., et al. (2021). pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma. Journal of Nanobiotechnology, 19(1), 1–17.
Hu, D., Chen, L., Qu, Y., Peng, J., Chu, B., Shi, K., et al. (2018). Oxygen-generating hybrid polymeric nanoparticles with encapsulated doxorubicin and chlorin e6 for trimodal imaging-guided combined chemo-photodynamic therapy. Theranostics, 8(6), 1558.
Jaidev, L., Krishnan, U. M., & Sethuraman, S. (2015). Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy. Materials Science and Engineering: C, 47, 40–47.
Brandhonneur, N., Hatahet, T., Amela-Cortes, M., Molard, Y., Cordier, S., & Dollo, G. (2018). Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer. European Journal of Pharmaceutics and Biopharmaceutics, 125, 95–105.
Li, L., Xiang, D., Shigdar, S., Yang, W., Li, Q., Lin, J., et al. (2014). Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. International Journal of Nanomedicine, 9, 1083.
Keil, T. W., Feldmann, D. P., Costabile, G., Zhong, Q., da Rocha, S., & Merkel, O. M. (2019). Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 143, 61–69.
Anzar, N., Mirza, M. A., Anwer, K., Khuroo, T., Alshetaili, A. S., Alshahrani, S. M., et al. (2018). Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer. Journal of Molecular Liquids, 249, 609–616.
Kucharczyk, K., Rybka, J. D., Hilgendorff, M., Krupinski, M., Slachcinski, M., Mackiewicz, A., et al. (2019). Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications. PLoS One, 14(7), e0219790.
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., et al. (2009). Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. European Journal of Pharmaceutical Sciences, 37(3-4), 300–305.
Xu, X., Koivisto, O., Liu, C., Zhou, J., Miihkinen, M., Jacquemet, G., et al. (2021). Effective delivery of the CRISPR/Cas9 system enabled by functionalized mesoporous silica nanoparticles for GFP-tagged Paxillin knock-in. Advanced Therapeutics, 4(1), 2000072.
Tammaro, O., Costagliola di Polidoro, A., Romano, E., Netti, P. A., & Torino, E. (2020). A microfluidic platform to design multimodal PEG-crosslinked hyaluronic acid nanoparticles (PEG-cHANPs) for diagnostic applications. Scientific Reports, 10(1), 1–11.
Chu, K. S., Hasan, W., Rawal, S., Walsh, M. D., Enlow, E. M., Luft, J. C., et al. (2013). Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. Nanomedicine: Nanotechnology, Biology and Medicine, 9(5), 686–693.
Hasan, W., Chu, K., Gullapalli, A., Dunn, S. S., Enlow, E. M., Luft, J. C., et al. (2012). Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. Nano Letters, 12(1), 287–292.
Chatterjee, M., Jaiswal, N., Hens, A., Mahata, N., & Chanda, N. (2020). Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications. Materials Science and Engineering: C, 114, 111029.
Rasekh, M., Ahmad, Z., Cross, R., Hernández-Gil, J., Wilton-Ely, J. D., & Miller, P. W. (2017). Facile preparation of drug-loaded tristearin encapsulated superparamagnetic iron oxide nanoparticles using coaxial electrospray processing. Molecular Pharmaceutics, 14(6), 2010–2023.
Doane, T., & Burda, C. (2013). Nanoparticle mediated non-covalent drug delivery. Advanced Drug Delivery Reviews, 65(5), 607–621.
Jain, A., & Cheng, K. (2017). The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. Journal of Controlled Release, 245, 27–40.
Sivaram, A. J., Wardiana, A., Howard, C. B., Mahler, S. M., & Thurecht, K. J. (2018). Recent advances in the generation of antibody–nanomaterial conjugates. Advanced Healthcare Materials, 7(1), 1700607.
Chen, E. Y., Liu, W. F., Megido, L., Díez, P., Fuentes, M., Fager, C., et al. (2018). Understanding and utilizing the biomolecule/nanosystems interface. Nanotechnologies in Preventive and Regenerative Medicine. Elsevier, 207–297.
Martínez-Jothar, L., Doulkeridou, S., Schiffelers, R. M., Torano, J. S., Oliveira, S., van Nostrum, C. F., et al. (2018). Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting. Journal of Controlled Release, 282, 101–109.
Cengiz, B., Ejderyan, N., & Sanyal, A. (2022). Functional polymeric coatings: thiol-maleimide ‘click’chemistry as a powerful surface functionalization tool. Journal of Macromolecular Science, Part A, 1–13.
Kolb, H. C., Finn, M., & Sharpless, K. B. (2001). Click chemistry: Diverse chemical function from a few good reactions. Angewandte Chemie International Edition, 40(11), 2004–2021.
Oria, L., Aguado, R., Pomposo, J. A., & Colmenero, J. (2010). A versatile “click” chemistry precursor of functional polystyrene nanoparticles. Advanced Materials, 22(28), 3038–3041.
Yao, V. J., D'Angelo, S., Butler, K. S., Theron, C., Smith, T. L., Marchiò, S., et al. (2016). Ligand-targeted theranostic nanomedicines against cancer. Journal of Controlled Release, 240, 267–286.
Conde, J., Dias, J. T., Grazú, V., Moros, M., Baptista, P. V., & de la Fuente, J. M. (2014). Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Frontiers in Chemistry, 2, 48.
Zhang, L., Mazouzi, Y., Salmain, M., Liedberg, B., & Boujday, S. (2020). Antibody-gold nanoparticle bioconjugates for biosensors: synthesis, characterization and selected applications. Biosensors and Bioelectronics, 165, 112370.
Yoon, H. Y., Lee, D., Lim, D. K., Koo, H., & Kim, K. (2022). Copper-free click chemistry: Applications in drug delivery, cell tracking, and tissue engineering. Advanced Materials, 34(10), 2107192.
Pan, Z., Fang, D., Song, N., Song, Y., Ding, M., Li, J., et al. (2017). Surface distribution and biophysicochemical properties of polymeric micelles bearing gemini cationic and hydrophilic groups. ACS Applied Materials & Interfaces, 9(3), 2138–2149.
Liu, J., Li, J., Zhang, Z., Weng, Y., Chen, G., Yuan, B., et al. (2014). Encapsulation of hydrophobic phthalocyanine with poly (N-isopropylacrylamide)/lipid composite microspheres for thermo-responsive release and photodynamic therapy. Materials, 7(5), 3481–3493.
Zhu, H., & McShane, M. J. (2005). Loading of hydrophobic materials into polymer particles: implications for fluorescent nanosensors and drug delivery. Journal of the American Chemical Society, 127(39), 13448–13449.
Wang, Z., Wang, L., Prabhakar, N., Xing, Y., Rosenholm, J. M., Zhang, J., et al. (2019). CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy. Acta Biomaterialia, 86, 416–428.
Ping, Y., Guo, J., Ejima, H., Chen, X., Richardson, J. J., Sun, H., et al. (2015). pH-responsive capsules engineered from metal–phenolic networks for anticancer drug delivery. Small, 11(17), 2032–2036.
Wu, Y., Guo, J., Yang, W., Wang, C., & Fu, S. (2006). Preparation and characterization of chitosan–poly (acrylic acid) polymer magnetic microspheres. Polymer, 47(15), 5287–5294.
Senthilkumar, T., Lv, F., Zhao, H., Liu, L., & Wang, S. (2019). Conjugated polymer nanogel binding anticancer drug through hydrogen bonds for sustainable drug delivery. ACS Applied Bio Materials, 2(12), 6012–6020.
Ke, X., Tang, H., & Mao, H.-Q. (2019). Effective encapsulation of curcumin in nanoparticles enabled by hydrogen bonding using flash nanocomplexation. International Journal of Pharmaceutics, 564, 273–280.
Huang, Y., Mao, K., Zhang, B., & Zhao, Y. (2017). Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Materials Science and Engineering: C, 70, 763–771.
Chechetka, S. A., Yu, Y., Zhen, X., Pramanik, M., Pu, K., & Miyako, E. (2017). Light-driven liquid metal nanotransformers for biomedical theranostics. Nature Communications, 8(1), 1–19.
Sirianni, R. W., Zheng, M.-Q., Patel, T. R., Shafbauer, T., Zhou, J., Saltzman, W. M., et al. (2014). Radiolabeling of poly (lactic-co-glycolic acid)(PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography. Bioconjugate Chemistry, 25(12), 2157–2165.
Nash, M. A., Yager, P., Hoffman, A. S., & Stayton, P. S. (2010). Mixed stimuli-responsive magnetic and gold nanoparticle system for rapid purification, enrichment, and detection of biomarkers. Bioconjugate Chemistry, 21(12), 2197–2204.
Feczkó, T., Piiper, A., Pleli, T., Schmithals, C., Denk, D., Hehlgans, S., et al. (2019). Theranostic sorafenib-loaded polymeric nanocarriers manufactured by enhanced gadolinium conjugation techniques. Pharmaceutics, 11(10), 489.
Ke, C.-S., Fang, C.-C., Yan, J.-Y., Tseng, P.-J., Pyle, J. R., Chen, C.-P., et al. (2017). Molecular engineering and design of semiconducting polymer dots with narrow-band, near-infrared emission for in vivo biological imaging. ACS Nano, 11(3), 3166–3177.
Asem, H., Zhao, Y., Ye, F., Barrefelt, Å., Abedi-Valugerdi, M., El-Sayed, R., et al. (2016). Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging. Journal of Nanobiotechnology, 14(1), 1–16.
Hasannia, M., Abnous, K., Taghdisi, S. M., Nekooei, S., Ramezani, M., & Alibolandi, M. (2022). Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer. Journal of Nanobiotechnology, 20(1), 1–27.
Sun, M., Guo, J., Hao, H., Tong, T., Wang, K., & Gao, W. (2018). Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer. Theranostics, 8(10), 2634.
Jin, G., He, R., Liu, Q., Dong, Y., Lin, M., Li, W., et al. (2018). Theranostics of triple-negative breast cancer based on conjugated polymer nanoparticles. ACS Applied Materials & Interfaces, 10(13), 10634–10646.
Soultan, A. H., Lambrechts, D., Verheyen, T., Van Gorp, H., Roeffaers, M. B., Smet, M., et al. (2019). Nanocarrier systems assembled from PEGylated hyperbranched poly (arylene oxindole). European Polymer Journal, 119, 247–259.
Wei, J., Shuai, X., Wang, R., He, X., Li, Y., Ding, M., et al. (2017). Clickable and imageable multiblock polymer micelles with magnetically guided and PEG-switched targeting and release property for precise tumor theranosis. Biomaterials, 145, 138–153.
Liu, R., Zhao, J., Han, G., Zhao, T., Zhang, R., Liu, B., et al. (2017). Click-functionalized SERS nanoprobes with improved labeling efficiency and capability for cancer cell imaging. ACS Applied Materials & Interfaces, 9(44), 38222–38229.
Li, Y., Wu, Y., Chen, J., Wan, J., Xiao, C., Guan, J., et al. (2019). A simple glutathione-responsive turn-on theranostic nanoparticle for dual-modal imaging and chemo-photothermal combination therapy. Nano Letters, 19(8), 5806–5817.
Escobedo, J. O., Rusin, O., Lim, S., & Strongin, R. M. (2010). NIR dyes for bioimaging applications. Current Opinion in Chemical Biology, 14(1), 64–70.
Kalchenko, V., Shivtiel, S., Malina, V., Lapid, K., Haramati, S., Lapidot, T., et al. (2006). Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. Journal of Biomedical Optics, 11(5), 050507.
He, X., Bao, X., Cao, H., Zhang, Z., Yin, Q., Gu, W., et al. (2015). Tumor-Penetrating Nanotherapeutics Loading a Near-Infrared Probe Inhibit Growth and Metastasis of Breast Cancer. Advanced Functional Materials, 25(19), 2831–2839.
Nogues, I. F. T., Goutayer, M., Da Silva, A., Guyon, L., Djaker, N., Josserand, V., et al. (2009). Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. Journal of Biomedical Optics, 14(5), 054005.
Cao, S., Pei, Z., Xu, Y., & Pei, Y. (2016). Glyco-nanovesicles with activatable near-infrared probes for real-time monitoring of drug release and targeted delivery. Chemistry of Materials, 28(12), 4501–4506.
Lee, M. H., Yang, Z., Lim, C. W., Lee, Y. H., Dongbang, S., Kang, C., et al. (2013). Disulfide-cleavage-triggered chemosensors and their biological applications. Chemical Reviews, 113(7), 5071–5109.
Perera, K., Nguyen, D. X., Wang, D., Kuriakose, A. E., Yang, J., Nguyen, K. T., et al. (2022). Biodegradable and Inherently Fluorescent pH-Responsive Nanoparticles for Cancer Drug Delivery. Pharmaceutical Research, 1-15.
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019). Hypoxia-modified cancer cell metabolism. Frontiers in Cell and Developmental Biology, 7, 4.
Justus, C. R., Dong, L., & Yang, L. V. (2013). Acidic tumor microenvironment and pH-sensing G protein-coupled receptors. Frontiers in Physiology, 4, 354.
Zhang, Q., Weber, C., Schubert, U. S., & Hoogenboom, R. (2017). Thermoresponsive polymers with lower critical solution temperature: from fundamental aspects and measuring techniques to recommended turbidimetry conditions. Materials Horizons, 4(2), 109–116.
Nagy-Simon, T., Diaconu, O., Focsan, M., Vulpoi, A., Botiz, I., & Craciun, A.-M. (2021). Pluronic stabilized conjugated polymer nanoparticles for NIR fluorescence imaging and dual phototherapy applications. Journal of Molecular Structure, 1243, 130931.
Zhu, H., Fang, Y., Miao, Q., Qi, X., Ding, D., Chen, P., et al. (2017). Regulating near-infrared photodynamic properties of semiconducting polymer nanotheranostics for optimized cancer therapy. ACS Nano, 11(9), 8998–9009.
Rohatgi, C. V., Harada, T., Need, E. F., Krasowska, M., Beattie, D. A., Dickenson, G. D., et al. (2018). Low-bandgap conjugated polymer dots for near-infrared fluorescence imaging. ACS Applied Nano Materials, 1(9), 4801–4808.
Seo, D., Park, J., Shin, T. J., Yoo, P. J., Park, J., & Kwak, K. (2015). Bathochromic shift in absorption spectra of conjugated polymer nanoparticles with displacement along backbones. Macromolecular Research, 23(6), 574–577.
Botiz, I., Freyberg, P., Leordean, C., Gabudean, A.-M., Astilean, S., Yang, A. C.-M., et al. (2015). Emission properties of MEH-PPV in thin films simultaneously illuminated and annealed at different temperatures. Synthetic Metals, 199, 33–36.
Botiz, I., Codescu, M.-A., Farcau, C., Leordean, C., Astilean, S., Silva, C., et al. (2017). Convective self-assembly of π-conjugated oligomers and polymers. Journal of Materials Chemistry C, 5(10), 2513–2518.
Cai, H., Wang, X., Zhang, H., Sun, L., Pan, D., Gong, Q., et al. (2018). Enzyme-sensitive biodegradable and multifunctional polymeric conjugate as theranostic nanomedicine. Applied Materials Today, 11, 207–218.
Lock, L. L., Cheetham, A. G., Zhang, P., & Cui, H. (2013). Design and construction of supramolecular nanobeacons for enzyme detection. ACS Nano, 7(6), 4924–4932.
Schneider, G. F., Subr, V., Ulbrich, K., & Decher, G. (2009). Multifunctional cytotoxic stealth nanoparticles. A model approach with potential for cancer therapy. Nano Letters, 9(2), 636–642.
Luo, K., Yang, J., Kopečková, P., & Ji, K. (2011). Biodegradable multiblock poly [N-(2-hydroxypropyl) methacrylamide] via reversible addition− fragmentation chain transfer polymerization and click chemistry. Macromolecules, 44(8), 2481–2488.
Key, J., Aryal, S., Gentile, F., Ananta, J. S., Zhong, M., Landis, M. D., et al. (2013). Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging. Biomaterials, 34(21), 5402–5410.
Kolouchova, K., Groborz, O., Cernochova, Z., Skarkova, A., Brabek, J., Rosel, D., et al. (2021). Thermo-and ROS-responsive self-assembled polymer nanoparticle tracers for 19F MRI theranostics. Biomacromolecules, 22(6), 2325–2337.
Sarkar, S., Graham-Gurysh, E. G., MacNeill, C. M., Kelkar, S., McCarthy, B. D., Mohs, A., et al. (2020). Variable molecular weight nanoparticles for near-infrared fluorescence imaging and photothermal ablation. ACS Applied Polymer Materials, 2(10), 4162–4170.
Min, H. S., You, D. G., Son, S., Jeon, S., Park, J. H., Lee, S., et al. (2015). Echogenic glycol chitosan nanoparticles for ultrasound-triggered cancer theranostics. Theranostics, 5(12), 1402.
Cao, Z., Feng, L., Zhang, G., Wang, J., Shen, S., Li, D., et al. (2018). Semiconducting polymer-based nanoparticles with strong absorbance in NIR-II window for in vivo photothermal therapy and photoacoustic imaging. Biomaterials, 155, 103–111.
Goos, J. A., Cho, A., Carter, L. M., Dilling, T. R., Davydova, M., Mandleywala, K., et al. (2020). Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect. Theranostics, 10(2), 567.
Ho, L.-C., Hsu, C.-H., Ou, C.-M., Wang, C.-W., Liu, T.-P., Hwang, L.-P., et al. (2015). Unibody core–shell smart polymer as a theranostic nanoparticle for drug delivery and MR imaging. Biomaterials, 37, 436–446.
Lee, J., Min, H.-S., You, D. G., Kim, K., Kwon, I. C., Rhim, T., et al. (2016). Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma. Journal of Controlled Release, 223, 197–206.
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., et al. (2007). Transvascular delivery of small interfering RNA to the central nervous system. Nature, 448(7149), 39–43.
Son, S., Jang, J., Youn, H., Lee, S., Lee, D., Lee, Y.-S., et al. (2011). A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials, 32(21), 4968–4975.
Chung, M. F., Chen, K. J., Liang, H. F., Liao, Z. X., Chia, W. T., Xia, Y., et al. (2012). A liposomal system capable of generating CO2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis. Angewandte Chemie International Edition, 51(40), 10089–10093.
McCarthy B, Cudykier A, Singh R, Levi-Polyachenko N, Soker S. (2021). Semiconducting polymer nanoparticles for photothermal ablation of colorectal cancer organoids. Scientific Reports 11(1), 1-12.
Wielenga, V. J., Heider, K.-H., Johan, G., Offerhaus, A., Adolf, G. R., van den Berg, F. M., et al. (1993). Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53(20), 4754–4756.
Shao, J., Liang, R., Ding, D., Zheng, X., Zhu, X., Hu, S., et al. (2021). A Smart multifunctional nanoparticle for enhanced near-infrared image-guided photothermal therapy against gastric cancer. International Journal of Nanomedicine, 16, 2897.
Yang, Z., Cheng, R., Zhao, C., Sun, N., Luo, H., Chen, Y., et al. (2018). Thermo-and pH-dual responsive polymeric micelles with upper critical solution temperature behavior for photoacoustic imaging-guided synergistic chemo-photothermal therapy against subcutaneous and metastatic breast tumors. Theranostics, 8(15), 4097.
Yan, L., & Qiu, L. (2015). Indocyanine green targeted micelles with improved stability for near-infrared image-guided photothermal tumor therapy. Nanomedicine, 10(3), 361–373.
Böger, C., Warneke, V. S., Behrens, H.-M., Kalthoff, H., Goodman, S. L., Becker, T., et al. (2015). Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer. Gastric Cancer, 18(4), 784–795.
Lisanti, M. P., Martinez-Outschoorn, U. E., Lin, Z., Pavlides, S., Whitaker-Menezes, D., Pestell, R. G., et al. (2011). Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs" fertilizer". Cell Cycle, 10(15), 2440–2449.
Pellosi, D. S., Calori, I. R., de Paula, L. B., Hioka, N., Quaglia, F., & Tedesco, A. C. (2017). Multifunctional theranostic Pluronic mixed micelles improve targeted photoactivity of Verteporfin in cancer cells. Materials Science and Engineering: C, 71, 1–9.
Ren, W. X., Han, J., Uhm, S., Jang, Y. J., Kang, C., Kim, J.-H., et al. (2015). Recent development of biotin conjugation in biological imaging, sensing, and target delivery. Chemical Communications, 51(52), 10403–10418.
Vadlapudi, A. D., Vadlapatla, R. K., Pal, D., & Mitra, A. K. (2013). Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT). International Journal of Pharmaceutics, 441(1-2), 535–543.
Li, J., Cai, P., Shalviri, A., Henderson, J. T., He, C., Foltz, W. D., et al. (2014). A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood–brain barrier targeting brain metastases of breast cancer. ACS Nano, 8(10), 9925–9940.
Kreuter, J. (2013). Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). Journal of Microencapsulation, 30(1), 49–54.
Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S., & Langer, K. (2007). Covalent attachment of apolipoprotein AI and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain. Journal of Controlled Release, 118(1), 54–58.
Cong, Z., Zhang, L., Ma, S.-Q., Lam, K. S., Yang, F.-F., & Liao, Y.-H. (2020). Size-transformable hyaluronan stacked self-assembling peptide nanoparticles for improved transcellular tumor penetration and photo–chemo combination therapy. ACS Nano, 14(2), 1958–1970.
Son, J., Yang, S. M., Yi, G., Roh, Y. J., Park, H., Park, J. M., et al. (2018). Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo. Biochemical and Biophysical Research Communications, 498(3), 523–528.
Yang, Y., Zhang, Y.-M., Li, D., Sun, H.-L., Fan, H.-X., & Liu, Y. (2016). Camptothecin–polysaccharide co-assembly and its controlled release. Bioconjugate Chemistry, 27(12), 2834–2838.
Liu, Y., Feng, L., Liu, T., Zhang, L., Yao, Y., Yu, D., et al. (2014). Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. Nanoscale, 6(6), 3231–3242.
Xiao, Y., Hong, H., Javadi, A., Engle, J. W., Xu, W., Yang, Y., et al. (2012). Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials, 33(11), 3071–3082.
Santra, S., & Perez, J. M. (2011). Selective N-alkylation of β-alanine facilitates the synthesis of a poly (amino acid)-based theranostic nanoagent. Biomacromolecules, 12(11), 3917–3927.
Hua, S., De Matos, M. B., Metselaar, J. M., & Storm, G. (2018). Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Frontiers in Pharmacology, 9, 790.
Luque-Michel, E., Imbuluzqueta, E., Sebastián, V., & Blanco-Prieto, M. J. (2017). Clinical advances of nanocarrier-based cancer therapy and diagnostics. Expert Opinion on Drug Delivery, 14(1), 75–92.
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., et al. (2004). Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clinical Cancer Research, 10(11), 3708–3716.
Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S.-B., et al. (2008). Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Research and Treatment, 108, 241–250.
Podoltsev, N., Rubin, M., Figueroa, J., Lee, M., Kwon, J., Yu, J., et al. (2008). Phase II clinical trial of paclitaxel loaded polymeric micelle (GPM) in patients (pts) with advanced pancreatic cancer (APC): Final results. Journal of Clinical Oncology, 26(15_suppl), 4627.
Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S., Kim, J., et al. (2007). Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Annals of Oncology, 18(12), 2009–2014.
Kim, C., Bae, S., Lee, N., Lee, K., Park, S., Kim, D., et al. (2006). Phase II study of Genexol (paclitaxel) and carboplatin as first-line treatment of advanced or metastatic non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology, 24(18_suppl), 17049.
Matsumura, Y. (2008). Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Advanced Drug Delivery Reviews., 60(8), 899–914.
Matsumura, Y. (2008). Polymeric micellar delivery systems in oncology. Japanese Journal of Clinical Oncology, 38(12), 793–802.
Burris, H., III, Infante, J., Spigel, D., Greco, F., Thompson, D., Matsumoto, S., et al. (2008). A phase I dose-escalation study of NK012. Journal of Clinical Oncology, 26(15_suppl), 2538.
Kato, K. (2008). PhaseI study of NK012, polymer micelle SN-38, in patients with advanced cancer. Proc Ams Soc Clin Oncol GI.
Matsumura, Y., & Kataoka, K. (2009). Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Science, 100(4), 572–579.
Caster, J. M., Patel, A. N., Zhang, T., & Wang, A. (2017). Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 9(1), e1416.
Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., et al. (2004). Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. British Journal of Cancer, 90(11), 2085–2091.
Armstrong, A., Brewer, J., Newman, C., Alakhov, V., Pietrzynski, G., Campbell, S., et al. (2006). SP1049C as first-line therapy in advanced (inoperable or metastatic) adenocarcinoma of the oesophagus: a phase II window study. Journal of Clinical Oncology, 24(18_suppl), 4080.
Valle, J., Lawrance, J., Brewer, J., Clayton, A., Corrie, P., Alakhov, V., et al. (2004). A phase II, window study of SP1049C as first-line therapy in inoperable metastatic adenocarcinoma of the oesophagus. Journal of Clinical Oncology, 22(14_suppl), 4195.
Ventola, C. L. (2017). Progress in nanomedicine: approved and investigational nanodrugs. Pharmacy and Therapeutics, 42(12), 742.
Weiss, G. J., Chao, J., Neidhart, J. D., Ramanathan, R. K., Bassett, D., Neidhart, J. A., et al. (2013). First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies. Investigational New Drugs, 31, 986–1000.
Funding
No funds, grants, or other support were received.
Author information
Authors and Affiliations
Contributions
Donald Fernandes contributed and was involved in all aspects of the work.
Ethics declarations
Ethical Approval
Not applicable
Conflict of Interest
The author declares no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fernandes, D.A. Theranostic Polymeric Nanoparticles for Cancer. BioNanoSci. 13, 1609–1644 (2023). https://doi.org/10.1007/s12668-023-01151-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12668-023-01151-9